Boise State University

ScholarWorks
Materials Science and Engineering Faculty
Publications and Presentations

Department of Materials Science and Engineering

5-6-2019

Synergy and Timing: A Concurrent Mass Medical
Campaign Predicted to Augment Indoor Residual
Spraying for Malaria
Richard C. Elliott
Boise State University

David L. Smith
University of Washington

Dorothy C. Echodu
Pilgrim Africa

(2019) 18:160
Elliott et al. Malar J
https://doi.org/10.1186/s12936-019-2788-9

Malaria Journal
Open Access

RESEARCH

Synergy and timing: a concurrent mass
medical campaign predicted to augment indoor
residual spraying for malaria
Richard C. Elliott1,2*, David L. Smith3 and Dorothy C. Echodu2

Abstract
Background: Control programmes for high burden countries are tasked with charting effective multi-year strategies
for malaria control within significant resource constraints. Synergies between different control tools, in which more
than additive benefit accrues from interventions used together, are of interest because they may be used to obtain
savings or to maximize health impact per expenditure. One commonly used intervention in sub-Saharan Africa is
indoor residual spraying (IRS), typically deployed through a mass campaign. While possible synergies between IRS and
long-lasting insecticide-treated nets (LLINs) have been investigated in multiple transmission settings, coordinated
synergy between IRS and other mass medical distribution campaigns have not attracted much attention. Recently, a
strong timing-dependent synergy between an IRS campaign and a mass drug administration (MDA) was theoretically
quantified. These synergistic benefits likely differ across settings depending on transmission intensity and its overall
seasonal pattern.
Methods: High coverage interventions are modelled in different transmission environments using two methods: a
Ross–Macdonald model variant and openmalaria simulations. The impact of each intervention strategy was measured
through its ability to prevent host infections over time, and the effects were compared to the baseline case of deploying interventions in isolation.
Results: By modelling IRS and MDA together and varying their deployment times, a strong synergy was found when
the administered interventions overlapped. The added benefit of co-timed interventions was robust to differences in
the models. In the Ross–Macdonald model, the impact compared was roughly double the sequential interventions in
most transmission settings. Openmalaria simulations of this medical control augmentation of an IRS campaign show
an even stronger response with the same timing relationship.
Conclusions: The strong synergies found for these control tools between the complementary interventions demonstrate a general feature of effective concurrent campaign-style vector and medical interventions. A mass treatment
campaign is normally short-lived, especially in higher transmission settings. When co-timed, the rapid clearing of the
host parasite reservoir via chemotherapy is protected from resurgence by the longer duration of the vector control.
An effective synchronous treatment campaign has the potential to greatly augment the impact of indoor residual
spraying. Mass screening and treatment (MSAT) with highly sensitive rapid diagnostic tests may demonstrate a comparable trend while mass LLIN campaigns may similarly coordinate with MDA/MSAT.
Keywords: Malaria, Vector control, IRS, MDA, MSAT, Synergy, Spraying, Ross–Macdonald models,
Openmalaria simulation
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Background
With 76% of the world’s entire malaria morbidity burden borne by just 13 nations, and malaria prevalence
related to both micro and macrocroeconomic indicators of poverty, those countries most burdened tend also
to be those least able to afford its suppression [1–4]. As
GDP growth and malaria are negatively correlated [2],
national malaria control programmes and their partners
in endemic countries must manage effective malaria control within stringent budget constraints. And this problem is getting more severe: spending per person at risk
in the highest burden countries has reduced even further
in the last three years, creating challenges for continued
global progress towards malaria eradication [1]. Though
effective interventions to stem transmission are relatively
expensive, the cost of failing to control malaria is higher,
both in lost health and in hindered economic growth [3,
4]. Prudence and good strategy are necessary to balance
up-front with ongoing costs for malaria control.
Elimination, however lengthy the journey may be, is
the most important goal for all control programmes. As
the only stable result that avoids the burden of continued,
intensive control efforts, it also limits or avoids acquired
resistance in parasites and mosquitoes. The human and
economic costs of maintaining elimination are also lower
than those associated with achieving it, so it is desirable
to reach elimination quickly. Malaria control programme
designers in high burden countries face the challenge of
finding the fastest, most effective, and least expensive
route from endemic disease to pre-elimination and from
pre-elimination to elimination, while applying continual downward pressure on transmission. Provided that
no resurgence occurs, and that costs can be contained
within budget limits, it is axiomatic that optimal routes
to elimination are those that lower transmission as rapidly as possible [5]. Countries with high or moderately
high transmission have special interest in cost-effective
control combinations capable of producing large, rapid
reductions in transmission.
Synergy in malaria control is the interaction of two or
more control interventions that produces a combined
impact greater than the sum of their separate effects.
Synergies have the potential to increase health impact per
dollar spent in a malaria control strategy, and therefore to
save programmes money. Possible synergies in integrated
vector management, principally between indoor residual spraying (IRS) and long-lasting insecticide-treated
nets (LLINs), have been eagerly explored for this reason.
Unfortunately no strong, super-additive advantage to
using both of these vector interventions together has yet
emerged [6–9], and even where the combination appears
somewhat more effective than either intervention alone
the effect is only found at certain transmission intensities
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[8]. Potential synergies with novel control methods have
also been examined [10]. Somewhat surprisingly, synergies between vector control campaigns and medical campaigns have not been well explored from a theoretical
and quantitative point of view, although there has been
some consideration of potential synergies and/or antagonisms between LLINs and vaccines [11].
Any control interventions exhibiting synergies with
the most common forms of vector control could create
large cost savings by maximizing the impact of the interventions. This is particularly true for IRS due to its high
programmatic cost in insecticide and labour. In 2015, 106
million people were protected by IRS, 49 million of them
in Africa. Since IRS is effective in medium to high transmission areas, [12–14]), while at the same time expensive, the decision to use it often depends on available
funding [15, 16]. IRS coverage in Africa actually dropped
to 45 million people in 2016, despite the increasing use of
more effective next generation insecticides, due to programme concerns around cost [1]. Synergies between IRS
and other control tools could maximize the health impact
per cost of this effective intervention by deepening its
impact.
Besides the widespread use of LLINs and IRS for vector control, endemic countries also invest heavily in
anti-malarial medicines, primarily artemisinin-based
combinations (ACT) for the treatment of disease. These
medicines also act as powerful control tools to reduce
transmission [17, 18]. In 2016, more than 196 million
ACT doses were distributed by sub-Saharan NCMPs in
the public sector [1] and the majority of these ACT doses
were not distributed via mass campaigns, but rather
intermittently and continuously through case management of uncomplicated malaria [19].1 Given the large
combined global investment in medical and vector control, it is worth exploring possible cooperation between
these two sets of tools. Synergies between IRS and the
mass synchronized use of effective malaria medicines are
particularly attractive, because high burden communities
already see high use of such medicines. From a resource
perspective, MDA in such a setting might be considered a “rearrangement” of effective treatment courses
otherwise consumed in case management. In this way, a
relatively small investment of labour might augment the
impact of an existing IRS programme, preventing infections otherwise requiring intensive case management
and treatment.
IRS is almost always applied with a mass campaign,
in which coverage is expanded population-wide within

1

The noted exception that an estimated 15–25 million children received seasonal malaria chemoprophylaxis [1, 77].

Elliott et al. Malar J

(2019) 18:160

a short period of time, and initiates effective, yet impermanent control; these campaigns are dynamic in time.
Consequently, synergies between the deployment of vector control campaign, IRS, and a mass medical campaign,
whose dynamics of control are also time-dependent, are
explored. Of note, the distribution of LLINs is also almost
always applied via mass campaign, and the same reflections around the dynamic nature of protection apply to
this ubiquitous form of vector control as well. Recently,
a robust synergy between these campaigns, MDA with
a concurrently deployed IRS campaign, was noted and
theoretically quantified [20]. As both the IRS and MDA
campaigns exert control over transmission differently,
and with different durations, this synergy is dependent
on their relative times of deployment. Below, these interventions are deployed at differing separations in time and
at different transmission intensities, in order to illustrate
and quantify any super-additive impacts of deploying
general vector control together with a mass medical campaign of anti-malarials. Though it is not explicitly modelled below, it should be noted that mass screening and
treatment (MSAT) is a campaign-style medical intervention of the same type as MDA. MSAT impact on the reservoir of parasitaemia depends on the sensitivity of the
diagnostics used, but will generally be lower than MDA.
MSAT, however, may well be more palatable to national
control programmes or to communities than MDA, and
if highly sensitive RDTs are used to detect parasitaemia,
the impact of a high coverage MSAT will approach that
of an MDA campaign. Similarly, an IRS campaign is
modelled below, though the results are likely applicable
for comparable campaign style form of vector control, in
particular LLINs with short-lasting insecticides and/or a
fast attrition rate.
It is recognized that MDA is more successful in the
presence of vector control [21]. Though potential synergies between MDA and IRS, and their dependence on
timing, have not previously been rigorously quantified,
the combined impacts of a joint campaign have nevertheless historically been recognized and employed.
A notable example is the Garki project, which investigated many aspects of transmission and the effects of
some control strategies on various transmission intensities [22, 23]. IRS and MDA were deployed both as isolated campaigns and together. When IRS and MDA were
deployed in tandem, at high coverage (85%), the campaigns achieved a high level of control, “the prevalence
of parasitaemia decreased very rapidly and varied in the
1–5% range, according to season [22].” Prevalence was
in many cases suppressed to very low levels, although
elimination was not achieved. Similarly, combined MDA
and LLIN campaigns in Henan Province in China in the
late 1990s and early 2000s were shown to be generally
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effective in maintaining a stable low rate of infection [24].
Sustained interruption of transmission has been reported
from combined use of IRS and MDA in highland Uganda
in 1960 [25], and intriguingly also from combined MDA
and LLIN campaigns in Vanuatu [26]. Of course, many
more isolated MDA [27–29], and IRS campaigns [30, 31]
have been carried out more recently, with varying successes, and recently reviewed for the Asia Pacific region
[32] and Africa [33, 34]. The most common vector control efforts in Africa, both LLINs and IRS, generally focus
on endophagic vectors, with outdoor/residual transmission largely overlooked. The role of outdoor transmission
is expected to become increasingly important as vector
behaviour changes and prevalence drops, but for many
high burden areas, it seems that the endophagic vectors
play a critical role for transmission, and will be the focus
below.
Recent investigations in sub-Saharan Africa indicate
large short-term prevalence reductions from a comprehensive MDA campaign, especially in low transmission
environments [29, 35]. These lend some justification to
the current WHO recommendation for MDA, namely,
that it be used either in areas approaching elimination
or for control of epidemics in a time-limited sense (such
as during complex emergencies like the recent Ebola crisis) [36]. However, the WHO guidelines call for more
implementation research and explicitly support the
use of modelling to guide the optimum use of MDA in
a programme setting. In particular, the increased health
impacts and/or reductions in costs that could be obtained
by co-deploying vector control together with an MDA or
an alternate mass medical campaign like MSAT warrant
careful examination.
All high transmission settings require vector control.
Both IRS and LLINs are recommended for use in high
transmission settings [37]. IRS can be even more effective
than LLINs at these intensities [12, 13], particularly when
potent, long-lasting insecticides are used [14]. Often,
IRS strategy involves transmission reductions achieved
through years of repetitive sprayings [38], and as IRS is
a resource intensive intervention, such multi-year efforts
are expensive to achieve. Below, the use of an MDA
campaign as an amplifier or “accelerant” for a jointly
deployed IRS is explored; if the addition of MDA greatly
augments the impact of an IRS campaign and allows
reductions to be achieved with fewer rounds of spraying and/or fewer treatment courses of ACT, significant
cost savings may ensue. A comparable accelerating or
amplifying role for a medical campaign was suggested by
Macdonald [39], “There is no reason to suspect that the
adequate use of potent insecticides, if properly checked,
should not result in the elimination of African malaria
in its most stable form, but the cost in insecticide and

Elliott et al. Malar J

(2019) 18:160

labour is bound to be high[er] ...Economy is to be sought
by the combination of insecticidal attack with such methods as effective mass treatment to reduce the period of
operation.”
The proposed use of a carefully timed MDA (or MSAT)
as a potential vector control accelerant in a high transmission setting also differs conceptually from its use in
an elimination setting. Communities saddled with high
transmission experience high ACT use as a matter of
course, and in some areas consume more than one ACT
dose annually per capita. Given the chemical pressure
already extant in highly infected communities from frequent case management, an MDA or MSAT in such settings may not necessarily increase overall ACT use, but
instead could be seen as a temporal and demographic
reorganization of existing ACT consumption. Rather
than planning to employ MDA or MSAT campaigns for a
long period of time, starting from high transmission and
continuing until elimination is achieved, a co-deployment
of MDA or MSAT together with LLINs or IRS could be
used for short periods (several rounds of each, perhaps)
to achieve much-needed deep reductions to a “new normal.” This new low might afterwards be sustained by integrated community case management and ongoing vector
control.
Modelling helps to generate an understanding of the
mechanisms of transmission control, and to uncover
potential synergies [20, 40, 41]. Recent modelling efforts
have investigated similar control interventions and combinations [19, 42–45]. Generally, campaign-style control
measures are carried out as finite programmes that are
deployed, have a prescribed duration, and then promptly
end. Post-campaign (with exception), the modelled community rebounds to its previous transmission balance
where malarial infections are again prevalent. As such,
below, elimination scenarios are not considered directly
but the process of large-scale reductions in the host and
vector reservoirs are examined as an important component of the elimination pathway.

Methods I: Interventions in a variant of the classical
model
Medical and vector-based campaigns address different stages of the transmission cycle. Medical campaigns
such as an MDA affects and diminishes the human reservoir of parasitaemia, and contrastingly, vector control
campaigns target mosquitoes and deplete the vector reservoir. During an MDA campaign, a community’s host
reservoir is cleansed; the MDA kills parasites, and offers
all those covered a limited prophylactic period of perhaps
2–4 weeks depending on the anti-malarial used. Transmission is directly affected in proportion to coverage as
fewer hosts harbour parasites that are passed on to the
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mosquito, and the momentum of host infection→vector
transmission→new host infection is slowed. Biting however continues undeterred.
An IRS campaign provides a different mechanism of
control: there is no therapeutic aspect and transmission
is instead decelerated through the reduced biting from
a diminished vector population. These interventions are
complementary to each other in that they target the two
sequestered parasite populations, those of the host and
the vector. As both these reservoirs refill at certain rates,
it is natural to wonder what combination and timing of
reservoir cleansing of parasites in humans and mosquitoes is capable of producing the largest reduction in
malaria.
To investigate these questions, and to compare different methods of suppressing infections in a model community, both a Ross/Macdonald model variant and
openmalaria simulations are employed. And specifically,
the combination of MDA with IRS in very generic transmission contexts is considered in both modelling efforts.
Given their importance in moderate to high transmission settings, only relatively potent interventions are
modelled, and this analysis is limited to a consideration
of effective, high-coverage campaigns. The isolated and
combined impacts of these interventions are investigated
for a few different transmission settings.
Interventions in the Ross/Macdonald model are simply incorporated as control efforts temporarily reducing
transmission via the reproductive number, R0. The MDA
and IRS campaigns are considered first independently,
which serves to introduce their different mechanisms
of bottlenecking transmission. Writing R0 = bcC/r , the
basic reproductive number is the rate infections invade
the community bcC divided by the rate r they depart.
C is the vectorial capacity and b and c are transmission
efficiencies mosquito-to-human and vice-versa; hosts
recover from infection at an average rate of r. Thus, during a campaign that modifies one or both of these rates,
the reproductive number changes, R0 → R0I , with the
superscript I referencing the reproductive number during an intervention. Reductions may be achieved through
enhanced mosquito mortality during an IRS which
affects C, or through (say) diminished human infectious periods from a medical campaign, which changes
r. Interventions modeled below are just finite periods
of bottlenecked transmission, and this is a tremendous
simplification and a useful approximation. The periods of intervention activity/duration are estimated, and
dynamical trajectories for the host and vector infectious
populations are calculated through the intervention periods with R0I < R0 and associated parameters, described
in more detail below. When the intervention concludes,
the transmission intensity immediately reverts back
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Fig. 1 Normalized trajectories for human X̄ , and mosquito Z̄ infectiousness with an applied, model MDA or IRS at (nondimensional) time τ = 10.
The application period of the interventions is highlighted in the panels. The upper panels display the longer-lasting effects of campaigns in
lower-transmission environments, R0 = 5, while the lower panels show the much shorter recoveries for moderate transmission environments,
R0 = 50. Bars on the left indicate the half-life estimates of Eq. 1 for regaining pre-intervention equilibria. The dashed line in the lower right shows a
limit for the vector control explained in the text

to pre-intervention levels, restoring R0I → R0, also an
approximation. The system subsequently relaxes according to these ambient conditions. At this time, transactions of parasites between human hosts and mosquitoes
return without the dynamical constraints set by the intervention, albeit with depleted parasite reservoirs. As is
well known [20, 46], the Ross/Macdonald dynamical system may relax to only one of two stable points: the trivial
equilibrium of elimination, or to a stable transmissive
environment where parasites are exchanged freely and
there are measurable populations of infectious hosts and
mosquitoes. In all cases considered below, post-intervention the system relaxes to this latter fixed point, and
elimination is not considered.
Mass drug administration

At its simplest, transmission is affected two-fold during
an MDA campaign, reduced first through the accelerated
rate infections depart a community with an administered
anti-malarial, and second, through chemoprophylaxis.
Both of these effects directly modify the reproductive
number R0I during the effective period of the intervention
and change the dynamical course of the infectious populations. The first of these is an alteration of the human
infectious period r −1 ≈ 150 days [47], whose average
wanes with the campaign. During an MDA with good

coverage much of the host population has their carried
parasite load extinguished and thus overall has shortened infections, reducing r −1. This is accomplished in
the Ross/Macdonald variant with a rate amplification,
r → ξ r , with ξ > 1 for the effective period of intervention. The second alteration regards chemoprophylaxis,
the protective period of maybe 2–4 weeks (set below to
be 2 mosquito lifetimes), where mosquito-to-human
transmission is greatly reduced due to the protection afforded by the anti-malarial. This is set by a second parameter reduction b → b/µ, corresponding to a
forced reduction in mosquito-to-human transmission.
Consequently, these two alterations greatly reduce the
reproductive number, R0 → R0 /µξ for the short duration of the intervention, and the campaign’s effect size
is R0 /R0I = µξ [44, 48, 49]. Just after the effective time
period of the MDA, these effects promptly expire and the
parameters r and b return to their pre-intervention values. Appendix A has more details on system dynamics
and intervention effects during the campaigns.
As might be expected of a medical intervention, these
modifications for the MDA campaign do not directly
alter the governing dynamics of infectious mosquitoes.
The campaign solely modifies the host parasite reservoir
and has repercussions in the vector only through subsequent, preempted transmission. This can be clearly seen
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in Fig. 1 (left panels) where the effects of a model MDA
campaign in the Ross/Macdonald variant are shown for
a low ( R0 = 5) and moderate ( R0 = 50) transmission setting. In the figure, the host infectiousness trajectory X,
and sporozoite rate Z, are normalized by their pre-intervention equilibrium values, X̄ = X/X ∗ and Z̄ = Z/Z ∗,
so they both initiate and, upon retraction of the intervention, bounce back towards equilibrium at X̄, Z̄ → 1.
These trajectories thus indicate percent reductions in
parasitaemia in the host or vector. On the abscissa, time t
is measured in mosquito lifetimes, τ = gt . It is clear that
during the prophylactic period of the MDA campaign, a
gray-highlighted region, with a diminished reproductive
number maintained at R0I = 0.5, system dynamics decay
temporarily towards elimination. The initial 85% reduction in X̄ = X/X ∗, is prominent, corresponding loosely
to achieved reductions with ∼ 85% campaign coverage
(compliance and adherence to the prescriptive treatment
is here assumed, and drug resistance is neglected). Notably, though, the sporozoite rate drops almost as quickly,
i.e. the vector parasite reservoir depletes in just a few
mosquito lifetimes. This is an important, first dynamical consequence of the effects of a medical intervention:
the sporozoite rate is labile with respect to changes in the
host reservoir. The MDA campaign targets and mostly
clears the large reservoir of parasites in hosts and this
quickly echoes in the much smaller vector reservoir; the
carried parasite load of the ephemeral mosquito population readily adjusts to changes in the host parasite
reservoir.
At τ = 12 in Fig. 1, when the prophylactic period
expires, host protection is promptly lost. Mosquitoes
continue to bite hosts though clearly fewer are infected
and those individuals who were previously protected
are eligible to become infected once again. A resurgence
takes place and the stable equilibrium of the pre-intervention transmission setting, X̄, Z̄ → 1, is re-equilibrated
in time. This property may be considered a resilience
of the system: the propensity for an endemic setting to
return to stable, widespread parasitaemia after a dynamical perturbation, which is here the MDA campaign.
Re-equilibration takes much more time in the low-transmission R0 = 5 setting than the higher transmission one
( R0 = 50), perhaps an obvious result, but if MDA is used
in isolation from a vector control intervention it clearly
has a more lasting impression in a low transmission or
elimination-ready context.
Employing the approximation mentioned above that
the transmission environment immediately reverts back
to pre-intervention settings post-campaign, i.e. setting R0
promptly back to its prior (pre-intervention) value, enables a linearized stability analysis. A characteristic time
to re-establish the pre-intervention equilibrium may be
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found. The time to regain half the number of infectious
individuals of the community’s previous stable equilibrium is approximately [20],


τm ≈ gfI−1 (X ∗ ) log 1 + X̄f−1 ,
(1)
where fI (X) is the force of infection, the rate at which
successful, infectious bites are received per host. It is a
function of the infected host proportion at the intervention’s expiry [46], and of the stable transmission setting
prior to the intervention. The logarithm in Eq. 1 boosts
the characteristic time by a factor related to the depth of
infection suppression achieved by the intervention. The
host prevalence at the conclusion of the intervention (at
τ = 12 for the MDA in Fig. 1) is denoted X̄f , and indicates that the lower host prevalence can be driven, i.e.
smaller X̄f , the longer it takes to re-establish the equilibrium level of parasitaemia. Thus, more effective MDA
campaigns (or other intervention) require longer times to
establish prevalent infections.
Equation 1 indicates the restoration rate, the resurgent rate malarial infections invade the community, is
essentially the force of infection of the pre- and postintervention entomological setting: the rate of viable
infectious bites of the system’s stable entomological
state. It sets the (perhaps obvious) pace in which malarial
infections invade the populace, after the intervention’s
control has been exerted. Equation 1 simplifies with,
fI (X ∗ ) ≈ rR0 /(1 + γ ) (γ is the average number of bites
in a mosquito’s lifetime that infects it) so that fI ∼ R0,
and the characteristic time of restoration (Eq. 1) scales
as τm ∼ R0−1, as has been previously noted in SI models [50, 51]. Thus, high transmission intensities become
parasitaemic faster post-intervention than do low ones, a
sensible trend seen easily in Fig. 1. Bars in the left MDA
panels indicate this approximate time to recover half the
infections in the populace. More details of this analysis,
which is again based on a linearized approximation, can
be found in reference [20].
The characteristic time of resurgence in Eq. 1 as an
approximation is most relevant for small changes in the
infectious densities, which clearly in Fig. 1 they are not.
This estimate is however not without merit given that
they illuminate the attributes of transmission that are
most responsible for the resurgence. It is worth noting
that the most conspicuous difference with R0 in Fig. 1 is
the variation in recovery times for the two transmission
settings post-intervention, a result emphasized with the
indicated half-lives. The scaling of this return to prevalent malaria in Eq. 1 with τm ∼ R0 −1 indicates the relative
recoveries differ by a factor of ten, and this matches the
figure extremely well. In passing, it is worth mentioning a
final interesting property of this relapse time set by fI−1:
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it does not endlessly shorten with R0 but in fact saturates,
ultimately achieving an asymptote g −1 fI (X ∗ ) ≈ 1 + γ
(for large R0), an intriguingly R0-independent result. This
is a consequence of the fast turnover of the vector population, their success in infecting hosts is ultimately limited by their short lifecycle [20].
It is furthermore important to recognize another limitation of this admittedly crude approach here. In a real
setting the transmission does not instantaneously revert
back to pre-intervention levels, as has been assumed
here, but more likely grows as a given intervention deteriorates. For this matter, the estimates of Eq. 1 should be
regarded as a fastest estimate for this characteristic resurgence time. This point will be revisited below for relevant
comparisons with simulation. Furthering this point, partial host immunity and heterogeneous host selection are
overlooked details in this analysis, and they too should
serve to lengthen the resurgence time.
Indoor residual spraying

An IRS campaign is an interesting counterpoint to MDA,
in which the local mosquito population is quickly and
dramatically reduced from exposure to applied insecticide. It may be taken as somewhat of a dynamical inverse
to a mass medical campaign: while synchronized medical treatment depletes the host reservoir, vector control
should serve to reduce the vector parasite reservoir. In
both cases, a sudden depletion in one reservoir forces the
response of the other. During mass medical treatment, it
was seen above that the vector responds very quickly to
an immediate alteration in host parasitaemia, and a fast
plummeting infectious vector proportion resulted. In just
a few mosquito lifetimes, the sporozoite rate falls and
becomes more commensurate with the infectious host
proportion. Based on this, a natural question arises: how
does the host reservoir dynamically respond to the sudden depletion of the vector reservoir?
To register the killing effects of a vector control campaign, the death rate of mosquitoes must get boosted
during the campaign. Amending this with a simple population model [20, 52] enables the approximation that
a simple boost in mosquito mortality, g → κg (κ > 1),
establishes an equilibrium of a smaller population of mosquitoes, and does so on a timescale shorter than a mosquito lifetime, (κg)−1 [20]. Working within this population
model, a diminished but static population of mosquitoes
results: the vector continues to be replenished at the same
rate but mosquitoes live shorter lives during the active
period of the campaign. As a consequence, the reduction
in the reproductive number during an IRS campaign is,

R0 ⇒ R0I = R0

[Pe ]κ−1
,
κ2

(2)

where Pe = e−gn is the survivorship of mosquitoes after
the latency time n. The scaling of the reproductive number in Eq. 2 with κ has been discussed previously [46].
Transmission is suppressed as κ 2 in the denominator with one power from the reduction in the mosquito
population, and a second from their shorter expected
lifespan. The factor of Peκ−1 results from the fewer older
mosquitoes present during the campaign that enable further transmission. Other than the coverage-related initial reduction and the campaign duration common to all
interventions, it should be noted that the IRS evolution is
configured with only a single parameter, κ (or R0I ), which
alone changes the dynamical course of the system during
the IRS period of bottlenecked transmission.
The dynamical effects of this model IRS campaign
for two transmission settings are shown in Fig. 1.
There is a marked reduction in Z̄ , synonymous to the
initial reduction in X̄ for the MDA, which is set by
Z̄(τ0 ) = (1 − c0 ) + c0 Pe κ−1, with coverage c0 taken to be
the percentage of all (relevant, proximal, host-seeking)
mosquitoes affected by the intervention initiating at τ0
[20]. The intervention duration is set comparable to that
of a typical insecticide, much longer for the IRS than the
immediate cleansing of an MDA campaign, and set here
to τ̄ = 18 (or 18g −1 ≈ 180 days), a time window highlighted in the figure. There is also no prescribed decline
in the efficacy in the insecticide; it is effective during the
18g −1 period of the IRS, and then subsequently inactive.
For a direct comparison with the MDA modeled above,
the augmentation of the mosquito mortality rate is again
set to preserve R0I = 0.5 for all transmission environments, a requirement that determines κ. The net killing effect disproportionately affecting older mosquitoes
forces a diminished sporozoite rate during the effective period of the IRS, seen in the figure, and the system
temporarily attracts to the stable node of elimination,
X̄, Z̄ → 0. Prevalent infectious densities then return
post-intervention when the community is subject to reinfection from the fast dynamics of the recovering vector
parasite reservoir. Z̄ quickly bounces back towards the
proliferation stable point and host infectiousness follows
( X̄, Z̄ → 1), the resurgent response rate scaling with the
ambient force of infection as before with the characteristic time of Eq. 1.
A striking contrast with the MDA campaign here
is that the host infectiousness X̄ responds slowly to
changes in the sporozoite rate Z̄ during vector control. Fast changes in X̄ result in fast changes in Z̄ in the
MDA above, but the reverse is not true. Figure 1 depicts
the slow decline in host infectiousness after the mass
killing of infectious mosquitoes during the IRS. In fact,
the sporozoite rate plummets for the effective duration of the insecticide (here roughly half a year), and
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Fig. 2 Normalized trajectories for host infectiousness X̄ with an applied, model MDA, IRS, or both, at (nondimensional) time τ = 10. The application
period of the interventions is again highlighted in the panels. The left panel is for the Ross/Macdonald theory variant and the right for openmalaria
with indicated transmission intensities. For MDA + IRS campaigns jointly administered, gains from the MDA quickly clearing the host reservoir
are sustained by the offered protection of the IRS. The insets show the intervention impacts I as defined in the text, Eq. 3, indicating the superior
suppression of infections for synchronous MDA + IRS

host infectiousness responds with a slow, consistent
decay. This asymmetry is a result of infections lost only
through their expiry at the natural host healing rate, r,
something directly modified by the MDA but summarily untouched by vector control. For comparison, the
lower right panel of Fig. 1 also shows the decay in host
infections in the limit of a vanishing inoculation rate, or
when zero successful host infections take place in the
active time of the IRS. It is drawn with a dashed line,
and represents the limit of a perfectly effective vector
control campaign. In short, the mechanism of protection offered by the IRS is to isolate the host reservoir
from replenishment, and it is only its long duration that
allows host infections to expire and clear, causing X̄
to wane. The IRS period, as modeled here, has only a
trickle of new infections due to a strongly suppressed
mosquito population, but with no mechanism or program in place to clear existing host infections, waiting
for them to heal at their slow rate is the only means to a
reduced presence of malaria in the community.
In summary, while the fast clearing of host infections in an MDA campaign results in a correspondingly
fast clearing of the vector reservoir, the cleansing of
the vector reservoir with an IRS does not result in the
fast clearing of the host reservoir. Host infections are
untouched with the vector control, and forced to clear
on their own natural timescale of r −1. In other words,
the flux of malaria out of the community is still slow
despite a heavy modification of the vectorial capacity, which greatly reduces its flux in. This indicates the
needed coordination of medical and vector control
efforts: the protection of a depleted host reservoir with
vector control may enable powerful gains.

Synchronous IRS and MDA

Given that the host and vector parasite reservoirs react
differently to the interventions, and especially in a rather
complementary manner, it is natural to next consider
their joint deployment. Host prevalence trajectories for
the synchronous deployment of an IRS and MDA are
plotted in Fig. 2 for the Ross/Macdonald theory and for
openmalaria, which will be discussed in more detail
below. Focusing first on the Ross/Macdonald variant,
synchronous deployment has both a depleted infectious
host proportion and reduced sporozoite rate for 85% coverage, in correspondence with the individual campaigns
considered above. The interventions are identical to those
described in the subsections above, with the same durations and parameter reductions common to those individual interventions. Here, dynamics are first determined
from the joint campaigns, for 10 ≤ τ ≤ 12, and just after
they evolve with the IRS, as its period of efficacy continues beyond the MDA, to τ = 28. Intervention durations
are indicated on the figure as before. As with the cases
above, at the moment of expiry of both campaigns, the
parameters revert back to those of transmission prior to
the interventions. Equilibrium is reestablished asymptotically, scaling as dictated by Eq. 1.
Prevalence is driven essentially to the pre-elimination
regime for either the Ross/Macdonald theory or openmalaria in Fig. 2 with joint campaigns, reminiscent of the
control reported by the Garki project [22]. But this figure also shows the coordinated means to obtaining this
control. First, host infectiousness is initially reduced by
the high coverage MDA, and rather than this control
being the short-lived improvement that the MDA campaign achieves alone, these gains are prolonged by the
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IRS. Vector control provides the needed protection for
a cleansed host reservoir; the initial depletion of host
infections established by the MDA is effectively sustained
by the IRS. Resurgence is delayed until the vector control
has faded.
In order to measure this effect, a simple metric of the
fitness of an intervention (or sequence of them) is the
number of host infections prevented through the course
of its effective time. Establishing this as a prevalence
reduction, rather than an absolute count of infections,
this impact is,

I = dτ [X̄0 (τ ) − X̄c (τ )],
(3)
where X̄0 (τ ) and X̄c (τ ) are the prevalence trajectories
for the community without interventions and with them,
respectively. X̄c (τ ) with subscript c denotes a trajectory
with included campaigns. Impact measures for the Ross/
Macdonald variant further simplify with X̄0 (τ ) = 1, the
prevalence absent interventions is that of the average
of the transmission setting. It is written generally here
because it will be applied to simulations below where
noise is present and X̄0 (τ ) � = 1, instead fluctuating about
unity. This impact is the area in Fig. 2 bound by the trajectories with campaigns, X̄c (τ ) and those without, X̄0 (τ ),
and is simply interpreted as the percentage of infections
prevented by the campaign times its effective time. As
such, a short duration campaign that deeply cleanses the
host reservoir, such as a high coverage MDA in a high
transmission setting, may have a net impact I comparable to a different, low coverage intervention with a correspondingly long duration (perhaps a bednet distribution
at modest coverage). The impact I measures the total
abilities of the intervention(s) to stem malarial infections.
By inspection alone, the impact shown in Fig. 2 (and the
insets) for joint campaigns exceeds that of the individual
interventions, and even their sum, indicating the coordination of their effects mentioned above.

Methods II: Openmalaria simulation of MDA, IRS
and LLINs
The right panel of Fig. 2 shows sets of trajectories for
openmalaria simulations, which are separately run as
a comparison for these interventions. Juxtaposed with
the semi-analytic Ross/Macdonald model, these trajectories and impacts provide an interesting comparison, in particular a novel setting for testing the synergy,
which is in fact immediately apparent in this figure.
These simulations model transmission and interventions entirely differently but arrive at remarkably similar conclusions.
Briefly, openmalaria is an agent-based simulator that
relies on a more sophisticated model of transmission and
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includes elaborations such as demographic heterogeneity,
partial immunity in the populace, the role of case management in health systems, and variable transmission/
infectivity based on a list of factors [53–60]. Notably, the
evolving, extrapolated load of parasite densities in inoculated hosts is monitored, and from it immune status and
host infectivity is inferred. The global entomology of a
simulation and various attributes of the vector(s) are also
separately configurable. Further discussion of many of
these features can be found in these references, and an
Appendix B details many of the settings of the simulations run here; the particular focus here is on a comparison with Ross/Macdonald theory. These elaborations of
the openmalaria model that make it unique are also not
turned off, which would serve to compare base models
of transmission (and interventions), but are rather deliberately included, within reason, to look in particular for
the resilience of this synergy in different modelling environments. For example, case management is present
(though it is very minimal), and acquired partial immunity is included, though clearly neither of these is present
in the Ross/Macdonald model. The intention here is to
see if an independent approach to the modelling yields
a comparable signature of intervention impact and timing. Adhering to general cases and some conventions for
all demography, entomology and interventions in simulation yields a reasonable comparison. And as indicated
in Fig. 2, some features of the interventions are in correspondence with the semi-analytic model.
Again, Fig. 2 (right panel) shows, for these openmalaria simulations, the three situations described above:
an isolated MDA, an isolated IRS, and their synchronous deployment. Eight trajectories are plotted for each
set indicating the dispersal of the prevalence profiles,
though as drawn they mostly overlap on the displayed
ordinate scale. The transmission intensity is set to an
annual entomological inoculation rate (EIR) of Ea = 25
bites/host*annum with no seasonal variation, based on
a correspondence with the reproductive number from a
separate investigation [61]. The prevalence trajectories
are normalized in the same manner as the Ross/Macdonald theory, which requires running separate simulations
to determine the average prevalence in the community without interventions. These simulations are run to
establish X ∗ (and Z ∗ if desired), the equilibrium values
for the infected host fraction, absent interventions. These
normalized simulation trajectories of Fig. 2 are for hosts
with any parasite density in their blood (those with 0.01
parasites/µL or greater) and not for patent hosts, a convention set for an apt comparison with the Ross–Macdonald model where hosts either harbour parasites or do
not. Intervention coverage is set to 85% with their durations as specified above and indicated on the figure. No
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pattern of insecticide decay is specified for the IRS in the
simulation, but it is rather generically configured as a step
function, on during its effective period and then abruptly
off. More details can be found in Appendix B.

Results
Infection suppression with combined vector control
and MDA campaigns modelled here is notably better
than additive, an effect seen easily in Figs. 1 and 2. Their
impacts for an isolated MDA, isolated IRS, and synchronous MDA + IRS are shown in insets to the figure
and demonstrate the enhanced suppression of the combined, jointly-administered interventions. In the Ross/
Macdonald variant, roughly twice as many infections
are prevented by a joint deployment of IRS and MDA in
comparison with an isolated MDA plus an isolated IRS
campaign.
A comparison of openmalaria simulations with the
Ross–Macdonald variant shows that the recovery times,
post-intervention, are much longer for the simulation.
The scale of the abscissa for the simulations is twice
that of the Ross/Macdonald variant to accommodate
the slower resurgence of parasitaemia in the simulated
community. The Ross/Macdonald analysis (Eq. 1) indicates the community regains half of its infected proportion for τm ≈ 3 ( R0 = 25) post-intervention. In contrast,
these simulations predict a half-life of resurgence several
times longer: at nearly three months post-intervention
(τ ≈ 20 for the MDA campaign alone) the Ross–Macdonald theory indicates the effects of the MDA are
essentially gone while it takes perhaps more than a year
for the equivalent equilibration in openmalaria. Malaria
invades the community post-intervention at a much
slower rate in openmalaria simulation, as noted above.
Since the relapse time of Eq. 1 is a fastest estimate, this
is not unexpected. The force of infection recovers and
slowly accelerates in the openmalaria simulation in this
time period, while it is assumed to revert immediately
to pre-intervention levels in the Ross/Macdonald analysis. Partial host immunity also slows resurgence, as was
explored earlier [20]. While the recovery rate is expected
to be slower in simulation, the question of whether it (or
any other resurgence rate) is a good quantitative estimate, especially within the context of non-spatial modeling, is uncertain.
The addition of a co-timed MDA to an IRS campaign
in Fig. 2 augments its impact by roughly three (in Ross/
Macdonald) or four (in openmalaria) times, depending
which method is used to model the IRS. The difference
is due to the fact that the openmalaria campaign for IRS
is plainly not as effective as the Ross–Macdonald variant.
As mentioned above, the rate r at which host infections
heal primarily determines the effective rate of infection
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loss in X̄ during the IRS, as (typically) only a trickle of
new infections impact the rate. In the openmalaria simulation, infections appear either to expire more slowly, or
to initiate more frequently during the IRS period. More
details of the IRS parameterization in openmalaria are
given in Appendix B, though the IRS potency is maximized in this application, with pre- and post-prandial
mortality affecting essentially all contacted mosquitoes.
The heterogeneity of host selection with a given, input
demographic, is an included sophistication of the openmalaria transmission model, and this may play a role in
weakening the modelled IRS campaign here. Regardless,
with either model, the large augmentation of IRS impact
upon addition of an MDA is striking.
Impacts of the interventions at variable transmission
intensities

Impacts are compared in Fig. 3 for a high coverage MDA
and IRS with varying transmission intensity R0. The top
panel shows impacts from the Ross/Macdonald model
and the lower from openmalaria. Again, the insets of
Fig. 2 show bar charts of the impacts I from the prevalence trajectories in the figure, and these correspond
with those in the top panel of Fig. 3 for R0 = 25. Impacts
at other transmission intensities R0 are calculated and
assembled for this figure and, for example, indicate the
strongly variable effects of the MDA, as apparent in
Fig. 1. As recovery times shrink with growing R0 (resurgence is faster in higher transmission settings), the
impact I(R0 ) of any intervention wanes. And while the
recovery time reaches an asymptote—mentioned above,
this rebound time τm asymptotes—this causes the impact
of each campaign to correspondingly saturate, an effect
readily seen in Fig. 3.
An IRS campaign is found to be generally more robust
than the MDA (with exception for R0  5) in the semianalytic theory, with static intervention transmission
intensities of R0I = 0.5, but is also relatively invariant
with transmission setting. Its impact at R0 = 20 is rather
comparable to that at R0 = 75. The impact decay of an
isolated MDA with R0 is far more apparent. It is very
assertive at low R0, something that has been recently
noted [29, 35].
Also shown in Fig. 3 (top) are two profiles of combined
interventions intended for comparison. The first shows
the impact of the joint, synchronous deployment of an
MDA with an IRS; this is always greater than the impact
of the (dashed) profile below it showing the additive
impact for these two interventions applied at separated
times. This is the synergy of these interventions, illustrated in Fig. 2 for R0 = 25, but shown here to be present
at essentially all transmission intensities. The impact with
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Fig. 3 Intervention impacts I from the Ross/Macdonald semi-analytic
theory (top) and openmalaria (bottom) as a function of transmission
intensity. In the upper panel, the solid lines show the impacts for the
MDA and IRS alone, and together, when synchronously deployed. A
dashed line indicates the impact of an IRS and MDA when applied
temporally in isolation, consisting of the sum of the two isolated
campaigns. Synchronous deployment far exceeds this impact,
and may be understood mechanistically in Fig. 2, where the initial
cleansing of the host reservoir from an MDA is maintained by the
IRS. In the lower panel, openmalaria simulations show the same
trends, though impacts are mostly greater since the recovery times
post-intervention boost their effective duration. For each R0, eight
simulations were run and their impacts plotted, though for most
intensities the overlap is significant compared with the point-size.
The connecting lines are drawn to guide the eye, and are used
to interpolate the dashed profile for the isolated MDA + IRS, in
accordance with the upper panel. One apparent contrast is the very
weak IRS in openmalaria compared to the semi-analytic model. All
interventions have 85% coverage, as before

synchronous deployment always exceeds, and almost
doubles, that of two isolated campaigns.
Corresponding openmalaria simulations are run
with and without interventions to calculate the impact
I(R0 ) for this transmission model, and are shown in the
lower panel of Fig. 3. For each R0, eight simulations are
run with and without the indicated intervention, and
the impacts of Eq. 3 summed. For each intervention, or
their combination, all eight values of I(R0 ) are displayed
on Fig. 3 though for larger R0 their points mostly overlap
on the figure appearing as a single point. The stochastic

noise is present throughout, though only plainly visible
for low R0; the variance about equilibrium is greater in
these settings resulting in a noisier impact I(R0 ). Both
single intervention MDA/IRS impacts have connecting lines on the figure to guide the eye, which are simply
averages over the eight simulations intended only to facilitate an apt comparison with the upper panel. The sum of
these averages is shown in the isolated MDA + IRS profile, which is an extrapolated net impact of two isolated
campaigns.
The signature of synergy is also apparent in these simulations, and is similar in character to that exhibited in
the Ross/Macdonald variant above. As a comparison,
the values of the impacts are first generally greater in the
simulations, a result of the slower recovery times postintervention, and this augments the effective duration
of any intervention and its impact I. Notably, also in the
comparison of models, the IRS is weaker for openmalaria
at essentially all transmission intensities and as a result,
an MDA combined with an IRS in openmalaria confers
an especially striking advantage when compared with
IRS alone. On the other hand, the MDA in openmalaria
is largely similar in appearance to the Ross/Macdonald in the top panel, with its assertive control at low R0
and strong R0−1 decay. Its comparatively longer recovery
in the simulation results in an impact that at large R0
asymptotes to a higher value than those in the Ross/Macdonald theory above. The IRS campaign, though weaker
than the MDA at nearly all transmission intensities,
intriguingly is comparably strong to the MDA for low R0
settings. In either case, the synergy of these interventions
is found and is of nearly the same magnitude: a doubling
(or more) of the impact of the interventions. A strong
synergy manifests at all transmission intensities for both
modelling techniques.
Timing medical and vector control interventions:
synchronous or near‑synchronous deployment boosts
impact

With all transmission parameters and environmental
conditions equal, Fig. 3 seems to indicate that the synchronous application of vector and medical control
via a campaign style intervention yields roughly twice
the combined impact of isolated campaigns, and from
three to four times the impact of solitary vector control
campaigns. It is clear that infected host populations are
robustly suppressed with a synchronous deployment
of complementary mass medical and vector control
interventions.
To see whether this synchronous deployment is in fact
the impact maximum, a deployment time of the IRS campaign is fixed in the middle of a window of duration τtot
of time, at τ = 0, for a few transmission settings, and the
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deployment time of the MDA is systematically changed.
A sweep of deployment times is performed for MDA
campaigns carried out far enough in advance of the vector control campaigns to be (essentially) fully in isolation
of the effects of them, to far enough post-campaign to
again be fully isolated. These limits of separation should
naturally agree for isolated campaigns. The synergistic
effect found above with their combined application will
have some signature, which is sought below through
a comparison of their impacts, varied for deployment
times.
A fractional impact of these two interventions,
deployed synchronously or not, is measured through a
comparison with a benchmark case: the same transmission setting with both interventions applied temporally in
isolation. For the Ross–Macdonald variant, a trajectory
with entirely isolated MDA and IRS campaigns, X̄iso (τ ),
is first run with interventions separated by several years
so that the system has essentially relaxed to the fixed
points of Eq. 7 before, between and after the individual
interventions. The fractional improvement with a given
timing, with respect to the isolated campaigns, is,

χs (τ0 ) = Ic (τ0 )/Iiso


dτ [X̄0 (τ ) − X̄c (τ )]
,
=
dτ [X̄0 (τ ) − X̄iso (τ )]

Ratio χs, the fractional improvement of
deploying an MDA at τ0
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Fig. 4 The fractional improvement χs of infection prevalence
reduction, defined in Eq. 4, as a function of the time of MDA
deployment, τ0. An impact of χs = 2 indicates the scheduling is
twice as powerful in suppressing infections compared to isolated
campaigns. The MDA timing is adjusted to that around a fixed IRS
deployment scheduled at τ = 0, as indicated. A nearly synchronous
deployment is most effective in suppressing infections/infectiousness
in the populace, a trend even more apparent for high R0. Nearly
double the potency is possible in a high transmission setting with
good campaign scheduling

(4)

where again X̄0 (τ ) and X̄c (τ ) denote the prevalence trajectories for host infectiousness without any interventions and with their combination, respectively. The
combination trajectory now includes an IRS at τ = 0
and the MDA at variable time τ0, which may precede,
be synchronous with, or follow the vector control campaign. Any value χs > 1 indicates a more effective, synergistic response to the interventions, and is the multiple
for which the MDA deployed at τ0 is more (or potentially
less) effective than the campaigns carried out in isolation.
The ratio χs = 2 indicates twice as many infections were
stymied by a given, scheduled programme; a synergy augmentation of two.
For an MDA deployed at τ0 beginning well in advance
of τ = 0, the time of the IRS campaign deployment
(τ = 0), to well after, the impact ratio χs (τ0 ) is calculated for each set of trajectories and is plotted in Fig. 4.
The ratio is shown as a function of this MDA deployment
time, τ0, for a few indicated transmission settings. First,
it is clear that both times far in advance and far after the
IRS at τ = 0 asymptote to χs → 1, so that the impact of
these timing sequences limits to that of the efficiency of
isolated campaigns. The nearly synchronous campaigns
modeled have a very strong complementary effect, especially at higher transmission. For R0 = 75, the synergy
is essentially double. This is, again, particularly important in considering programmatic design: with poor

intervention scheduling, that is, by isolating these MDA
and IRS campaigns, one is achieving somewhat less than
half of their potential effect. Even in a stable, low transmission environment, R0 = 12.5, one can achieve (better
than) half-again the potency of the interventions simply
by coordinating them. Given the programmatic choice of
an MDA in year one with an IRS in year two, or both at
the same time, the former appears to be a far less potent
option. Such a choice negates all gains afforded by the
synergy of these interventions.
Figure 4 also has a few interesting features in the profile. First, the maximum impact increases with transmission intensity. Second, the greatest impact is evident for
an MDA campaign preceding the IRS schedule by exactly
two mosquito lifetimes, 2g −1, that of the prescribed duration of the MDA chemoprophylaxis period (the timeperiod associated with the efficacy of the prescribed
anti-malarial). Those gains established by the MDA campaign are propagated by the sustaining power of the IRS.
In this efficient timing, an MDA campaign first causes an
abrupt disruption in host infectiousness, with X̄ instantly
reduced to just 15% of pre-intervention value. Dynamics during the short course of the campaign attract the
system briefly and weakly to the elimination point. Two
mosquito lifetimes later, the MDA intervention expires,
and host infectivity would begin resurgence and retract
towards X ∗ ( X̄ → 1) except for the precisely instantaneous application of an IRS which sustains the established
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Fig. 5 Simulation results for the fractional improvement χs in reducing host prevalence, defined in Eq. 4, as a function of the time of MDA
deployment τ0. Each panel corresponds to a different, labeled reproductive number R0 which is also taken to correspond with the annual EIR Ea
[61]. The MDA timing is measured with respect to the IRS deployment at τ = 0, as indicated. It is again clear that a synchronous deployment, or just
nearly so, preceding the IRS by the period of prophylaxis due to the MDA, is most effective in suppressing infections/infectiousness in the populace.
The effect is double or better with good campaign scheduling

MDA gains. And they are yet improved by the marked
reduction in vector population which mostly preempts
subsequent transmission.
A quick comparison of this scheduling, that of an MDA
applied a prophylactic period (2g −1) ahead of an MDA,
with the commensurate application of both MDA and
IRS at τ = 0, indicates that the sustaining effect of this
sequential ordering is only a slightly better suppressor of
infections in the community than exactly synchronous
deployment. Since these interventions are not carried
out precisely in an instant in practice, synchronous campaign deployment would seem to be a good policy. This
effect could however be significant in the case that a very
long-lasting anti-malarial with strong chemoprophylactic effect is administered. In such a circumstance, the
sequential deployment may prompt slightly higher gains,
provided the IRS follows the MDA within the prophylactic period. In a practical sense, synchronous deployment
is likely the best strategy.
Before moving on, a curious feature near the conclusion of the IRS campaign on Fig. 4 is worth mentioning,
where an MDA at the expiry of the effective period of the
IRS performs slightly poorer than interventions applied
in isolation (see τ0 ≈ 16 on the figure). At this point in
time, the IRS is concluding and has made its full impact,
and an MDA scheduled here therefore impacts the fewest
infected individuals (see, for example, X̄ at the conclusion
of the IRS campaigns in Fig. 1). If instead the IRS expires
fully prior to deploying the MDA, slightly more infectious
individuals would be treated, and delays the onset of the
rebound. This results in an incrementally greater overall
impact, but only just better than the isolated campaigns.

It is tepid; the period for really powerful gains using both
interventions has essentially passed.
Timing of IRS and MDA campaigns with openmalaria

The impact of these interventions and their timing in
simulations is again assessed with the fractional improvement χs, in Eq. 4 above, but for openmalaria simulations. Simulations are first run without interventions to
establish X̄0 (τ ), the prevalence trajectory divided by its
average value X ∗, and separately with the MDA and IRS
suitably isolated, determining X̄iso (τ ). Additional simulations are run for a fixed IRS at τ = 0 and variable MDA
at times τ0 before, during, and after the vector control
campaign, establishing the relative impact χs (τ0 ) of Eq. 4.
Results for eight trajectories are depicted in Fig. 5 for
three different transmission intensities, demonstrating
the absolute magnitude of the inherent stochastic noise.
As seen before in Fig. 4, an important attribute of Fig. 5
is the variable impact of the two interventions based on
their relative timing. For MDA deployments well before
or after the IRS at τ = 0, the impact decays towards that
of isolated campaigns, χs → 1. The longer equilibration
times in openmalaria merit a somewhat greater time
window on the abscissa, though the general form and
shape of the impact is impressively similar in both figures. In Fig. 5 as the campaigns overlap, their combined
impact grows, suppressing more infections. The trend is
markedly similar to that of the Ross–Macdonald impact
plot, Fig. 4, peaking at an MDA deployment time just
prior to the IRS campaign, and decays from this scheduling. The optimal deployment of one prophylactic period
prior to the IRS is also reproduced: the same lesson is
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Except for the very lowest transmission intensities,
synergistic deployment provides close to the double the
impact of additive, separate campaigns for all R0. Put
another way, the choice to add a carefully timed MDA to
an already scheduled mass vector control campaign has
the potential to nearly triple the impact.
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Fig. 6 Impact χs for best-case scheduling, an MDA preceding an IRS
campaign by the prophylactic period 2g−1, for different transmission
intensities. In both simulation and the Ross–Macdonald variant, the
impact of the interventions grows for small R0, generally increasing to,
or exceeding twice the impact of isolated campaigns. Interestingly,
while the Ross–Macdonald model is monotonic, with growing
impact for higher transmission intensities, openmalaria obtains a
maximal impact and slowly wanes. Simulation data is plotted in blue
(stochastic noise is apparent) and the grey highlighted background is
drawn only to guide the eye; it has no numeric merit

found in that the optimal strategy is to preserve the gains
of the MDA by sustaining them with an immediately
subsequent IRS. However, due to a latency in the vector
response a shift in deployment time is required for an
apt comparison with the initial killing impact of the IRS,
see Appendix B. Furthermore, it is also clear from both
Figs. 4 and 5 that MDA campaigns preceding the onset of
the peak IRS killing effect are slightly more effective than
the reverse. Just as in the Ross–Macdonald model, the
maximum possible synergistic impact increases slightly
with transmission intensity at these low to moderate
intensities, and is nearly 2.5 times the baseline impact for
R0 = 75.
Next, an optimized MDA and IRS joint intervention
is considered, and its maximal impact tracked for different transmission settings. Figures 4 and 5 both indicate
their maximal impact grows slightly with the transmission intensity R0. The campaign schedulings are fixed
to that of an MDA preceding the IRS by a prophylactic period, τMDA = τIRS − 2, and R0 is varied through a
larger range, running simulations and model trajectories
for both. Plotted in Fig. 6 are profiles produced by both
techniques, and show that the Ross–Macdonald variant
has a more conservative prediction, as foreshadowed in
the plots above, but also that openmalaria is interestingly rather non-monotonic. For transmission intensities
of Ea ≈ 25–50 bites/annum, the impact of the two campaigns is maximal, wanes thereafter, and likely asymptotes for higher transmission settings.

Discussion
Given the powerful and complementary dynamic impacts
that an MDA and IRS campaign exerts, respectively, on
the human and vector population reservoirs of parasitaemia, it is logical to wonder whether significant synergies between carefully co-timed MDA and vector control
interventions might exist. Such synergies have the potential to benefit control programmes struggling to make
headway towards elimination in a constrained funding
context.
In order to theoretically explore the nature and size
of these potential synergies, a simple Ross–Macdonald
variant with incorporated MDA and IRS interventions is
explored, and a concise analysis of their overall impacts
on population infection is carried out. Also included are
openmalaria simulations in an effort to ensure that this
effect and its size are not a feature of one modeling technique. The intent has been to uncover generalities that
are scaling-level trends which are model-independent by
nature.
The Ross/Macdonald theory has a number of limitations. Many complicating factors in both the modeled
entomology and epidemiology are neglected in this formalism which in effect strips the elements of transmission down to a minimum. For example, not only are
spatial considerations of transmission missing [62–64],
but the mobility of both mosquito and host populations
is absent [65–67]; imported parasites in the vector or
hosts are not considered. Similarly, host immunity and
super-infection are neglected, despite an oft-cited poor
performance of the model in a high-transmission setting for this reason [68]. Also overlooked are potential
heterogeneities in host selection, all but a few attributes
of the vector(s), the role of parasite densities in transmission events, and in-host dynamics of infections. The
mosquito population dynamics are restricted to maintain
a constant emergence rate that replenishes the population lost with mortality rate g. Other than during the IRS
campaign which kills mosquitoes by amplifying this rate
g → κg , the mosquito population maintains an average
value. More commentary on these complications (and
others) can be found in reference [69]. Disregarding
these influences, moderate (and stable [39]) transmission intensity environments might be most amenable
and relevant to the simple transmission dynamics and
model interventions here; infectious transactions in these
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settings may be assumed to be prevalent and several of
these complications may play less of a role. Following the
examination of the Ross/Macdonald variant are openmalaria simulations of MDA and IRS in order to demonstrate the strength and persistence of the observed effects
in the presence of more complicating factors.
Vector control efforts are also considered to be effective. For instance, transmission is presumed to be largely
dependent on endophagic vectors. Seasonal entomological trends are clearly also important for practical
applications, but are neglected in order to focus on the
effects of interventions in the absolute simplest of settings. Those geographies with highly-variable seasonality,
with finite periods of malaria transmission in the calendar year prompted from annual rains absent other times,
clearly require vector control to be deployed seasonally
for a strong impact. Any accompanying MDA scheduling
will likely also be similarly dominated by this seasonality,
and may compete with their coordinated effect. While
seasonal transmission may alter and compete with their
coordination, this presents a situation that is beyond the
scope of this investigation, which has instead focused
on inter-intervention dynamics. It is possible that coordinated interventions, albeit perhaps not co-timed ones,
may also predict large gains in seasonal transmission
environments.
Simulations were carried out using intentionally simplified settings in order to unmask the fundamental
transmission dynamics, and do not necessarily reflect a
specific entomological and epidemiological environment.
For example, vector biting in these simulations is carried
out by a single species. There is also extremely weak case
management and considerations of imported parasites in
hosts or vectors are neglected. More sophisticated (and
real) environments could be simulated but these embellishments might obscure the result. Case management,
for example, is represented as a health system parameterization in openmalaria but functions as an additional
intervention.
The Ross–Macdonald theory provides very useful
insight into the mechanism of the IRS–MDA augmentation seen in both models. Each intervention is first
modeled in isolation, with intensities of either of the
interventions set to the same coverage and R0I through
the duration of the campaigns, an attempt to put them
on equal ground considering transmission. Then, sweeping an MDA intervention’s timing beginning well prior
to a vector control campaign to far after, a signature of
intervention synergy is found when they are deployed
very nearly together. A far greater impact, determined
through the number of suppressed host infections, is
found when an MDA is deployed nearly synchronously
with an IRS campaign.
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The modelled MDA campaign reduces the host parasite reservoir by 85%, and having a modest chemoprophylactic effect, protects the recipients for a short
duration. After this, individuals are again susceptible
and infections are re-established. The simple dynamics
of the Ross/Macdonald model dictate that these infections restore an equilibrium, or balance of parasite
transactions, post-intervention. The timeline to this
re-equilibration, that of relaxing to the stable equilibrium point of freely exchanged parasites between the
host and vector reservoirs, is simply related to the force
of infection of the entomological setting the system
resurges into. High transmission has a fast return to a
proliferation of infections, a phenomenon explored in
greater detail in our prior publication [20].
The IRS campaign impacts the vector, changing the
effective entomological setting of the community.
During the intervention, with a diminished mosquito
population, the effective R0I is reduced. The campaign’s
longer duration of control, dictated by the effective
period of the insecticide, inhibits the transmission of
parasites by the vector during this period and leaves
hosts with (potentially) no other means of purging
infections except to clear them on their own slow timescale. Host infections/infectiousness wane very slowly
but they have protection from new infections through
the reduced vector population.
It is sensible that a strategy with combined campaigns
would have more impact than isolated campaigns. If
vector control can only offer the protection of reduced
biting, while leaving individuals to fight infections off
on their own, it is clear that a simultaneously deployed
MDA offers an additional, and otherwise absent, therapeutic benefit. The timing analysis shows a characteristic signature of impact when both campaigns are
deployed together, or nearly together, in time. Vector
control and medical control campaigns affect different
aspects of transmission, reducing the vector and host
reservoirs, respectively, which gives them complementary, better-than-additive coordinated abilities to prevent new infections. Because the different reservoirs
empty and refill at different dynamic rates, this complementarity is especially marked when vector and medical campaigns are deployed simultaneously, emptying
both reservoirs at once and constraining the “refilling”
to take place at the slower of the two dynamic rates.
This result is clear analytically from the Ross/Macdonald model but is also seen in the IRS and MDA
openmalaria simulations of Fig. 2. Gains in eliminating host infections by the MDA are in both cases are
prolonged by the vector control, just as is seen with the
Ross/Macdonald formalism.

Elliott et al. Malar J

(2019) 18:160

What is surprising is the size of the synergistic effect
when these interventions are optimally deployed. Each
intervention is powerful on its own, but in combination
are extremely suppressive. The co-timed vector/medical
campaign synergy is robust at all transmission intensities, but its exact trajectory varies by model, exhibiting
an asymptotically-constrained increase with intensity for
the simple model and a more complex non-monotonic
response in openmalaria. In both models the synergy
provides roughly twice the additive effect at high transmission intensities. The Ross/Macdonald model employs
the most basic of transmission dynamics, contains essentially no elaborations, has very few parameters and indicates a strong synergy, together with full transparency of
the forces and effects that enable it. The more complex
openmalaria simulation, incorporating a much broader
picture of transmission and many pertinent forces that
shape it, confirms this synergy, and in fact predicts an
even greater impact. These results, as they are general
features of combined vector and medical control campaigns, are also likely to extend to vector and medical
control campaigns with similar dynamic features.

Conclusions
IRS campaigns are a widespread, globally ubiquitous
method of vector control for malaria, used at all transmission intensities, and typically deployed via a mass
campaign of limited duration. It is a potent transmissionsuppressing intervention, if performed with high population coverage and effective insecticides. MDA is also a
potent campaign-style transmission-suppressing intervention, but current WHO guidelines recommend its
use primarily as an aid to elimination in very low transmission environments or for control in complex emergencies, while calling for operational research to further
elucidate a potential role in programme planning [1, 36].
The co-use of MDA and IRS is explored, with both a
semi-analytic model and openmalaria simulation. As
elucidated by the simple model, the IRS/MDA campaign
synergy is a consequence of the interplay of time scales
between the two reservoirs of parasitaemia: the deep
reservoir of infection in human hosts can be cleansed
rapidly with dynamic MDA, but if the system tends
towards a stable transmission equilibrium, will refill after
the period of chemoprophylaxis afforded by the acting anti-malarial, and at a rate determined by the force
of infection. Simultaneous deployment of vector control and MDA allows the human host reservoir to refill
at the longer time scale determined by the insecticide
used for vector control rather the shorter time scale of
the anti-malarial, and this produces a profound and lasting suppression of prevalence even in high transmission
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environments, provided coverage of both interventions is
high.
The synchronous or near synchronous deployment
of these two interventions maximizes these better than
additive gains; simultaneously deploying MDA together
with an existing vector control campaign confers, in general, close to double the additive impact of the MDA and
vector control campaign separated in time.
As MDA is a less common intervention than IRS, the
synergistic benefit might also be expressed as the impact
gained by adding an MDA to an existing vector control
campaign as an accelerant. In openmalaria, the addition of an MDA is shown to amplify the impact of an IRS
campaign by approximately four times its stand-alone
impact. This is a striking result, given the enormous
global investment in IRS.
This greater impact, if realized, could be translated
into better health outcomes or cost savings. IRS is an
intervention whose use is often limited by cost. An
MDA campaign strategically co-deployed to maximize
and amplify the effects of an IRS may reduce the number of spray rounds necessary to achieve a certain level
of disease reduction, and therefore reduce an overall IRS
investment. Widespread population LLIN deployment
is typically performed campaign-style and shares many
general features with the IRS modelled here. An MDA
strategically applied to amplify an LLIN campaign may
ensure the campaign achieves much higher impact than
it would in the absence of MDA.
The potential benefit of MDA as a vector control
accelerant should be researched and explored, though
it should be noted that its function is entirely distinct
from its use in an elimination setting. To deploy MDA in
a high transmission setting over and over until elimination is achieved would be both costly and dangerous in
terms of the development of drug resistance. MDA, used
synchronously with IRS, or potentially LLINs, in a high
transmission setting, may have a limited role to play in
initially optimizing the impact of the vector control, and
helping programmes reach steep reduction targets more
easily and cost effectively. Cost savings in some scenarios
may be very direct. In a high burden context, the treatment doses employed through MDA may prevent more
infections than they consume.
Once prevalence is dramatically reduced, and provided
that the new, achieved low in parasitaemia can be maintained without further campaign-style chemotherapy,
MDA would presumably be halted until late pre-elimination, as per current guidelines.
Even in this limited sense as a vector control accelerant, MDA may not be palatable for control programmes
or communities. Though it would be slightly more
expensive, a highly sensitive, specific MSAT with newer
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diagnostics could be substituted for an MDA. Though it
is not explicitly modelled here, a high coverage MSAT
with a highly sensitive diagnostic will likely have a similar strong synergistic impact to an MDA if co-deployed
with a vector control campaign. If such medical/vector
co-campaign strategies are successful in greatly reducing prevalence within a short time, and provided that
resurgence is prevented, they will also reduce community
chemical exposure over time, and the exposures so concerning for resistance.
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Appendix A: Basic dynamics and the model
interventions
Dynamics, considerations of stability and scope

Transmission is determined by a simple, homogeneous Ross/Macdonald model variant which describes
the dynamics of an infected/infectious subpopulation
of hosts who infect ambient anopheles mosquitoes and
vice-versa [46, 52]. The dynamics of the coupled infectious fractions are written,
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dX
= mabZ(1 − X) − rX,
dt

(5)



dZ
= acX e−gn − Z − gZ,
dt

(6)

for the proportions of infectious hosts X and mosquitoes Z. In the first expression, naive hosts of fraction
(1 − X) become infected through coupled events at the
rate mabZ, where a−1 is an average time between human
blood meals, b is the efficiency coefficient for mosquito-to-human transmission [70], and m is the population ratio of mosquitoes to humans. This first term is
the creation rate of new infectious hosts from the naive
host populace and is ignorant of the time lag of gametocyte development in hosts. Overlooking this latency,
the infected and infectious proportions of humans are
exactly equal. Host infections depart the population with
the rate r, or have an average duration of r −1. They are
only cleared by waiting out this period (in the absence
of medical treatment); deaths or migration are not considered. In the text, references to the “host reservoir” are
synonymous to the proportion X, though they are not
strictly equivalent.
The infectious proportion of mosquitoes Z, or sporozoite rate, is similarly constructed in Eq. 6, consisting of
creation and annihilation rates. Mosquitoes die at the
per-capita rate, g, which is the only means of diminishing
the infectious vector population. New infectious mosquitoes are created at the rate acX, coupling to the infectious host proportion X, and c is a human-to-mosquito
transmission efficiency. An extrinsic incubation period
for infectiousness n is incorporated here by diminishing the eligible infected vector population so that only
Pe = exp(−gn) of newly infected anopheles survive to
become infectious, a limitation based on the simple hazard model for mosquito survival. Incorporating the delay
in this way, albeit crudely, again avoids distinguishing
infected and infectious populations of mosquitoes, and
the need to monitor them separately. Mosquitoes are
assumed to carry infectiousness, once acquired, to their
death. The fixed points of the dynamical system of Eqs. 5
and 6 are those of elimination, X ∗ = Z ∗ = 0, and that of
infection proliferation,

X∗ =

R0 − 1
R0 + γ

and, Z ∗ =

ma2 bce−gn
with, R0 =
.
rg



γ Pe
R0



R0 − 1
,
1+γ

(7)
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The definitions, γ = ac/g and the reproductive number
R0 are introduced in these expressions. The former is
introduced in the text and is the average number of selfinoculating bites a mosquito makes over its lifetime and
R0 represents the local intensity of transmission.
All trajectories for R0 < 1 attract to the elimination
point, X̄ = Z̄ = 0 and all others attract asymptotically to
the stable, non-trivial equilibrium point {X ∗ , Z ∗ } of Eq. 7.
This is emphasized here because the control interventions considered here temporarily adjust the reproductive number, R0 → R0I . With good coverage and effective
chemoprevention and/or vector control, the reproductive number can fall below unity for the duration of the
intervention (high effect size [48]). In this period, dynamics exist on a trajectory that attracts towards elimination
but it will not result if retraction or intervention expiry
causes only a temporary reduction in transmission. The
rebounding, post-intervention R0 re-introduces higher
transmission and results in a dynamical resurgence to the
equilibrium of Eq. 7, re-establishing widespread infections in the community.
Equations 5 and 6 describe a dynamical overview of
the transmissive elements for infection and outline perhaps the simplest transmission model for host and vector dynamics. Infectious proportions are boosted by the
coupled density transmission events and diminished with
vector death or the expiry of host infections; these, again
in the absence of interventions, are the only means which
infections are gained or lost. The system above may be
simplified with two transformations, first dividing the
infectious populations by their (nontrivial) stable points,
X̄ = X/X ∗ and Z̄ = Z/Z ∗, and second, scaling time by
the mosquito lifetime τ = gt . The system transforms to,
 ∗
d X̄
Z
Z̄(1 − X ∗ X̄) − α X̄
=β
(8)
dτ
X∗

d Z̄
=γ
dτ




X∗
X̄(Pe − Z ∗ Z̄) − Z̄,
Z∗

(9)

and the following parameters have been introduced:
α = r/g is the mosquito lifespan divided by the human
infectious period, β = mab/g is the lifetime average number of successful infecting bites per host, and
γ = ac/g is again the number of bites in a mosquito’s lifetime that infects it. The reproductive number
is also simply expressed with the scaled parameters,
R0 = γβPe /α = bcC/r , which emphasizes its alternative
interpretation which is that it is the ratio of two rates,
that of infections invading the community γβPe , divided
by the rate they leave, α. The resulting dynamical system
in Eqs. 8, 9 (and thus Eqs. 5 and 6) is in fact fully specified by just four independent parameters, {R0 , γ , β, Pe }.

These are the transmission intensity of the setting R0, the
scaled interaction parameters for mosquito-to-human
mediated transmission and vice-versa (γ and β), and
lastly Pe = exp(−gn) is the proportion of mosquitoes that
survive the incubation period. With the introduction of
interventions below, their modelled effect will be to bottleneck transmission over a short period of time, reducing R0 → R0I through diminished mosquito-to-host or
host-to-mosquito interactions.
An exceedingly desirable aspect of this modelling is that
it is only a four parameter theory. The parameters are also
remarkably coherent, consisting of the transmission intensity, the asymmetric transmission-mediating coefficients,
and the extrinsic incubation period. As such a simple and
transparent system, the mechanisms for intervention success, as well as those forces that restore (or potentially
destabilize) equilibrium are simply illuminated and understood. In particular, this type of analysis affords a look at
the fast/slow return to equilibrium post-intervention, and
how it changes with transmission attributes.
Interventions as finite periods of bottlenecked
transmission

As outlined in the text, interventions are modelled as
control efforts which temporarily change the reproductive number through (say) enhanced mosquito mortality
or diminished human infectious periods. Effects such as
these suppress mosquito-to-host transmission or viceversa, and are modelled simply as short periods of bottlenecked transmission. For example, an MDA campaign
has r → ξ r and b → b/µ, or α I = ξ α and β I = β/µ (the
superscript again denotes intervention-period values).
All interventions are discussed in more detail in reference [20], which also describes how the augmented rates
of ξ and κ, as well as chemoprophylactic parameter µ, are
chosen while preserving the bottlenecked transmission
environment specified by R0I = 0.5. The periods of intervention activity/duration are approximated, and dynamical trajectories are calculated through the interventions,
via Eqs. 8 and 9, but with dynamics determined by a
reduced R0I and associated parameters. When the intervention ends, the system dynamically relaxes according
to the same ambient transmission conditions prior to
the intervention, with a restored pre-intervention reproductive number R0. Post-intervention the system regains
the fixed points of Eqs. 7, where parasites are freely
exchanged and measurable populations of infectious
hosts and mosquitoes exist at modest R0 > 1. This resurgence time mentioned in the text—the slow (or fast) reacquisition of parasitaemia in the community—including
the characteristic times of regaining equilibrium is
explored in more detail in reference [20].
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The time windows before, during and after an intervention are considered as highlighted in Fig. 1, and
system dynamics are interpolated by matching conditions for the transitions between them. The first time
period is a static trajectory, that of a community stuck
at the equilibrium with stable endemic malaria. Evolving dynamics for this pre-intervention time period are
elementary: parasites are exchanged freely from hosts to
mosquitoes and vice-versa, and the parasite reservoirs
are static. The second time window is that of the intervention which is brought about by an initiating impulse:
the transmission environment is, in an instant, changed
with the campaign. At the inception of the intervention, a proportion of the population (host or mosquito)
affected has their parasite reservoir cleansed. This
means, for example, when MDA is deployed and (say)
85% of a local population is treated, 85% of the infectious pool of humans has their parasite load cleared and
their infectious status is exactly voided. This value of the
infectious proportion is then used as an initial condition
for the subsequent dynamics of the intervention period,
with an associated set of reduced transmission parameters appropriate to the intervention. The time duration
of this second period is estimated, which for an MDA
is based on the duration of prophylaxis offered by the
particular drug administered. Upon expiry of the intervention, system dynamics return to those of the time
period prior to the intervention. The evolved infectious
proportions at the expiry of the intervention period are
used as initial conditions for the recovery stage, postintervention. This is the third time window, the period
of dynamical relaxation (which is a resurgence) subsequent to the intervention. Effects from a decaying intervention are not included, and, for example, insecticides
do not wane in their potency: interventions are taken to
be working or wholly ineffective. This level of analysis
is performed for simplicity and robustness, choosing
not to adorn or parameterize insecticides or individual pharmaceuticals. Their general effects of coverage,
duration, and effective transmissive impact are ascribed
for a given intervention.
All non-analytic and non-simulation results are full
solutions to the coupled nonlinear Eqs. 8 and 9, integrated numerically with a fourth-order Runge–Kutta
algorithm. Transmission parameter values are chosen in correspondence with previous work [47, 66,
71], which are γ = 0.642 , α = (150d)−1 /(10d)−1, and
Pe = 1/e.
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Appendix B: Details of openmalaria simulations
All simulations were run with the base model, which is
often referred to as R0001 [53, 60]. The background and
details of building and the determination of the integral 31 parameters which constitute the transmission
model are detailed elsewhere [53–60, 72]. Transmission
dynamics are discretized into 5-day timesteps for infectious/infectiousness status updates in hosts and mosquitoes, extrapolated parasite densities, forecasted acquired
immunity, and severity of malarial episodes. Some of the
dynamical ingredients present in the model for transmission in openmalaria, yet absent in the Ross/Macdonald variant, include superinfection, heterogeneous host
selection and transmission, and health systems access
and effects. Importantly, acquired partial immunity is
also included and may be a result of a high number of
prior episodes, and/or a history of high parasite densities,
or maternal protection.
Separately, openmalaria enables the entomology and
transmission elements dependent on the carrying capacity of the vector to be configured with an additional 16
parameters which specify the life and feeding cycle of
the vector(s). Vector transmission dynamics are specified
through a time-lagged deterministic difference equation
[73, 74] and tethered to host transmission through the
entomological inoculation rate (EIR). Transmission may
be parameterized to be seasonal through the EIR but is
here forced to be constant to afford a simple and direct
comparison. A single vector species, Anopheles gambiae,
whose parameters are chosen as previously specified [75]
(in an included supplement) is considered for simulations
here. The lone exception to these parameter assignments
is that the extrinsic incubation period is set to n = 10
days in accordance with the average lifetime g −1 mentioned in the text (which sets e−gn = e−1, and, for comparison it is n = 11 days in the reference).
A correspondence between the EIR, E , and the reproductive number R0 is needed to align the simulations
with the semi-analytic model. Reference [61] details different effective R0 values for openmalaria simulations
with varying treatment probabilities. For the case of the
base model without case management (essentially what is
considered in the text), the reproductive number roughly
corresponds with the annual EIR, or total bites per host
per annum, Ea = (365d)E . To this end, simulations were
run with annual EIR values in correspondence with the
reproductive number of the Ross/Macdonald analytic
model.
A very tepid health system is generically parameterized, exactly as detailed in the openmalaria wiki pages
[76]. Defaults for simulations where case management is
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not a primary interest of the simulation are used, including those for access, adherence, and compliance. Uncomplicated cases of malaria are treated for only 4% of the
populace and 48% of severe episodes are cured. Cure
rates are unity for those who access care. This very low
level of care allows reasonable correspondence with the
cases of reference [61]. Other case fatality rates are as is
typical as well as specified sequelae rates. These low rates
of care also assist in a reasonable reestablishment of prior
transmission environments post-intervention, something
necessary for the analysis in the text.
Interventions are modelled as closely as possible with
those described in the text for the semi-analytic model.
The effects of the IRS do not slowly decay but are on or
off through the use of a step function which activates
the intervention from deployment for a duration of 36
timesteps, or 18 g −1. The IRS is maximized in its mosquito killing impact, with preprandial and postprandial
killing effects set to 0.99; deterrence is set to zero. The
MDA is modelled as clearing the liver for 5 days and
blood for 4 timesteps, or 2 g −1. Coverage is 85% for both
interventions, corresponding to the text. To compare the
timing of interventions, the time index of initial intervention deployment is shifted for an apt comparison. This
means, for an IRS deployed at τ0 in the Ross/Macdonald
model, the sporozoite rate is instantaneously reduced at
this moment (as detailed in the text). An equivalent openmalaria deployment is begun at the shifted time τ0 −
(15 days/10 days), accounting for an inherent latency in
the sporozoite rate [73] to respond to the intervention.
On this note, the MDA timing is also shifted. An MDA
deployed within openmalaria at time t0 = kt has its
first effects at timestep k + 1, and thus comparisons are
made for a MDA deployed at τ0-(5d/10d) with a Ross–
Macdonald campaign deployed at τ0. In brief, for reasons
of simplicity, the timing of an IRS campaign is defined to
be the very moment that the sporozoite rate plummets.
Openmalaria takes about three timesteps (15 days) for
this effect to transpire while it is, as designed, exactly
immediate in the Ross–Macdonald intervention. This
convention is mostly chosen for convenience: it might
have instead matched the openmalaria standard, scheduling (for example) the Ross/Macdonald IRS with a full
killing effect transpiring after a 15 days latent period.
Simulations are performed on a population of
N = 10, 000 individuals with a demographic of that of
Ifakara, as detailed in [54]. As none of the analytic results
in the text above depend on demography, the distribution is rather irrelevant in this context, but necessary as
the force of infection is dependent on this distribution
in openmalaria. It was selected for generality and ease
of reproducibility, and also reflects the general youthfulness of many sub-Saharan populations. The choice of
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population size is not selected with a community in mind
but rather to simulate a large enough populace to have
statistical relevance with small fractional random error.
The multiple simulation results plotted demonstrate the
modest stochastic variance in trajectories.
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